AFME — Affluent Medical SAS Cashflow Statement
0.000.00%
Last trade - 00:00- €53.46m
- €62.87m
Annual cashflow statement for Affluent Medical SAS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2017 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.75 | — | — | -14.8 | -15.2 |
| Depreciation | |||||
| Non-Cash Items | 0.063 | — | — | 1.29 | 1.11 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.5 | -11.4 | -8.94 | -1.17 | 0.684 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.8 | -11.4 | -8.94 | -12.4 | -11.1 |
| Capital Expenditures | -0.263 | — | — | -0.334 | -0.146 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.007 | -0.185 | -0.304 | 0.174 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.27 | -0.185 | -0.304 | -0.16 | -0.146 |
| Financing Cash Flow Items | 2.29 | 3.16 | 1.33 | 1.51 | -0.512 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.4 | 10.4 | 12.8 | 18.3 | 2.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.25 | -1.21 | 3.52 | 5.76 | -8.83 |